Analysts' Top Healthcare Picks: Scholar Rock Holding (SRRK), Gilead Sciences (GILD)

TipRanksMay 23 07:20 ET

Berenberg Raises Price Target on Novartis to CHF77 From CHF74, Maintains Hold Rating

MT NewswiresMay 23 07:20 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB) and Incyte (INCY)

TipRanksMay 23 07:11 ET

Incyte Analyst Ratings

BenzingaMay 23 07:03 ET

Johnson & Johnson Analyst Ratings

BenzingaMay 22 10:07 ET

Wells Fargo Remains a Hold on Pfizer (PFE)

TipRanksMay 22 05:45 ET

Gilead Sciences (GILD) Gets a Hold From Wells Fargo

TipRanksMay 22 05:45 ET

Barclays Sticks to Its Hold Rating for Amgen (AMGN)

TipRanksMay 21 03:46 ET

HSBC Adjusts Price Target on Amgen to $356 From $322

MT NewswiresMay 20 07:48 ET

DA Davidson Raises Price Target on Pfizer to $35 From $30, Maintains Buy/Add Rating

MT NewswiresMay 20 07:16 ET

Citi Keeps Their Buy Rating on Johnson & Johnson (JNJ)

TipRanksMay 20 07:17 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Ionis Pharmaceuticals (IONS) and Ultragenyx Pharmaceutical (RARE)

TipRanksMay 20 02:10 ET

Adaptimmune Therapeutics Analyst Ratings

BenzingaMay 17 07:29 ET

Mizuho Slashes Price Target on Adaptimmune Therapeutics to $3 From $9, Keeps Buy Rating

MT NewswiresMay 17 06:49 ET

Johnson & Johnson Analyst Ratings

BenzingaMay 16 12:43 ET

Johnson & Johnson (JNJ) Receives a Buy From RBC Capital

TipRanksMay 16 06:30 ET

Analysts Conflicted on These Healthcare Names: Fortress Biotech (FBIO), GoodRx Holdings (GDRX) and Adaptimmune Therapeutics (ADAP)

TipRanksMay 16 05:10 ET

Incyte's Share Buyback Program: A Buy Rating and Fundamental Value Increase

TipRanksMay 16 04:07 ET

TD Cowen Sticks to Its Buy Rating for Adaptimmune Therapeutics (ADAP)

TipRanksMay 15 10:55 ET

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Bluebird Bio (BLUE) and Nuvalent (NUVL)

TipRanksMay 14 06:40 ET